Propiedad y actividad de insiders de Candel Therapeutics, Inc. (CADL): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $11.02 |
| Capitalización | $807M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-10 | Tak Paul Peter | M-Exempt | 125,000 | $194K |
| 2026-09-10 | Tak Paul Peter | M-Exempt | 125,000 | $194K |
| 2026-09-10 | Tak Paul Peter | S-Sale | 220,866 | $2.5M |
| 2026-09-11 | Tak Paul Peter | S-Sale | 59,379 | $621K |
| 2026-09-08 | Zimmermann Martine | A-Award | 64,000 | $806K |
| 2026-09-08 | Zimmermann Martine | |||
| 2026-08-17 | Tyagarajan Seshu | S-Sale | 7,000 | $84K |
| 2026-07-06 | Sims Mark E. | A-Award | 285,000 | $2.9M |
| 2026-07-06 | Sims Mark E. | |||
| 2026-06-29 | Barone Francesca | S-Sale | 23,447 | $236K |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $5.2M | $35.1M | $82.6M | $70.1M | $35.4M | $102.7M | $119.7M |
| Inversiones a Corto | $39.9M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $45.2M | $35.1M | $84.9M | $71.9M | $36.8M | $103.8M | $119.7M |
| Inmovilizado Material | $425000 | $2.8M | $3.8M | $5.5M | $4.0M | $2.7M | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $45.9M | $38.3M | $89.2M | $78.5M | $41.2M | $106.9M | $125.2M |
| Cuentas por Pagar | $218000 | $921000 | $1.6M | $380000 | $422000 | $237000 | $1.1M |
| Deuda a Corto | 0 | $463000 | 0 | $464000 | $8.9M | $9.9M | $445000 |
| Pasivos Corrientes | $1.4M | $4.7M | $5.4M | $5.6M | $14.2M | $37.5M | $9.0M |
| Deuda a Largo | $420000 | $483000 | $560000 | $20.9M | $12.4M | $2.6M | $1.5M |
| Pasivos Totales | $53.9M | $61.8M | $25.1M | $30.8M | $28.5M | $40.5M | $73.3M |
| Reservas | -$26.5M | -$44.2M | -$80.3M | -$99.1M | -$137.0M | -$192.2M | -$230.4M |
| Patrimonio Neto | -$8.0M | -$23.6M | $64.1M | $47.7M | $12.7M | $66.3M | $51.9M |
| Deuda Total | $420000 | $946000 | $560000 | $22.8M | $22.8M | $13.5M | $1.9M |
| Deuda Neta | -$44.6M | -$34.1M | -$82.1M | -$47.3M | -$12.7M | -$89.2M | -$117.8M |
| Capital Circulante | $43.8M | $30.4M | $79.6M | $66.3M | $22.6M | $66.3M | $110.7M |
Salud financiera
| Deuda / Patrimonio | 0.39 |
| Ratio corriente | 16.09 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -0.34 |
Rentabilidad
| Rentabilidad sobre capital | -89.38% |
| Rentabilidad sobre capital invertido | -36.74% |
| Rentabilidad sobre activos | -42.53% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ALDX · CABA · CAPR · CTNM · EDIT · GNLX · IMMP
Explorar sector: Healthcare · Biotechnology
Más secciones de CADL: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones